Sign in
CompletedNo phase

Establishing a Pediatric Reference Range for the 13C-Spirulina Gastric Emptying Breath Test (GEBT)

Key facts

Who runs it
Cairn Diagnostics
Where
Brentwood, Houston, and Milwaukee, United StatesSee the 3 sites
Trial code
Status
Completed
People taking part
182 people enrolled
Started
17 Mar 2023
Ended
30 Sept 2024
Type of study
Interventional, 2 groupsOne group gets an existing treatment, for comparison.
Treatments tested
  • 13C-Spirulina Gastric Emptying Breath Test (GEBT)
  • 13C-Spirulina Gastric Emptying Breath Test (GEBT) - repeat
Record updated
3 October 2024

Who can take part

Age
7 years to 18 years
Sex
Women and men
Healthy volunteers
Can take part

The registry criteria, word for word

Show all 11 criteriaShow less

Who can take part

  • Children ages 7 to 18 years who provide written assent and whose parents provide written consent for participation
  • Healthy and without any significant prior medical history or developmental delays
  • Able to eat the test meal and provide breath samples.-

Who cannot take part

  • Chronic pulmonary disease including moderate/severe reactive airway disease requiring treatment with a daily inhaler
  • Currently receiving prescription drug therapy that may affect gastric motor function or sensation
  • Any known physician-diagnosed medical (gastrointestinal, pancreatic, or liver disease that may cause malabsorption, neurological) or psychiatric disease
  • Type 1 or 2 Diabetes
  • Chronic gastrointestinal symptoms or functional gastrointestinal disorders
  • Mental retardation or pervasive developmental disorder
  • Allergy to Spirulina, egg, milk, wheat or gluten (unless consuming gluten free crackers with the test meal) or known intolerance to any ingredient in the test meal
  • Any over-the-counter or herbal supplements that may affect gastric motor function or sensation

Where in United States

  • Cairn DiagnosticsBrentwood, United States
  • Texas Children's Hospital/ Baylor College of MedicineHouston, United States
  • Medical College of WisconsinMilwaukee, United States

About the trial

What the trial wants to find out

The goal of this clinical trial is to define the normal response to the 13C-Spirulina Gastric Emptying Breath Test (GEBT) in children, so that we can use this test to help diagnose children that are suspected of having a condition called gastroparesis, which means that food doesn't empty from their stomach normally.

Read full original descriptionShow less

Participants will blow into test tubes to collect breath samples before and after eating a scrambled egg GEBT meal that contains a small amount of specially grown Spirulina (a blue-green alga used as a dietary supplement) that contains mostly carbon-13 (a non-radioactive kind of carbon atom). Analysis of the amount of 13C in the carbon dioxide in breath before and after eating the GEBT meal can measure how fast food is emptying from the stomach.

The 2 groups in the trial

  • Reference Range determinationOther group

    13C-Spirulina Gastric Emptying Breath Test (GEBT) administered to healthy participants

    Treatment: 13C-Spirulina Gastric Emptying Breath Test (GEBT)

  • Biological VariabilityExisting treatment, for comparison

    13C-Spirulina GEBT administered a second time to subset of participants to determine pediatric biological variability.

    Treatment: 13C-Spirulina Gastric Emptying Breath Test (GEBT) and 13C-Spirulina Gastric Emptying Breath Test (GEBT) - repeat

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Record updated
3 October 2024